BioNTech SE ADR
BNTX: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| DLZ | LOCK|t< | LOCK|>hGy>t |
BioNTech Earnings: Guidance Narrowed Higher Despite Lower Covid Vaccine Sales
BioNTech reported third-quarter revenue of EUR 1.29 billion, a 15% year-on-year decline, driven by lower covid vaccine sales. Management raised its guidance to EUR 1.7 billion-EUR 1.9 billion, or 3% higher at the midpoint. Shares fell 1% from the previous day's close.
